Literature DB >> 8781617

Vascular smooth muscle cells and neointimal hyperplasia in chronic transplant rejection.

J G Geraghty1, R L Stoltenberg, H W Sollinger, D A Hullett.   

Abstract

Intimal hyperplasia is the characteristic pathological hallmark in the arterial tree of chronically rejecting solid organ grafts. Mechanisms underlying the development of this lesion are poorly understood. One strongly held hypothesis is that vascular smooth muscle cells (vs.mcs) migrate from the medial layer of arteries contained within the graft into the intima forming the "neointima" characteristic of intimal hyperplasia. This study investigated this theory in a rat aortic allograft model of intimal hyperplasia. It also examined the possibility, using a combination of immunocytochemistry and electron microscopy, that aortic vs.mcs may undergo a phenotypic change during this process. Intimal area in syngeneic grafts was 3509 +/- 4325 pixels (n = 5) compared with 240,896 +/- 87,042 in allogenic grafts (n = 9, P < 0.001) 12 weeks after transplantation. At that time medial nuclear density was markedly reduced in the same allografts compared with corresponding syngeneic grafts (0.83 +/- 0.14 versus 2.64 +/- 0.60, P < 0.001, respectively). The most striking finding was that there was strongly positive staining for alpha-actin cells in the neointima in association with an almost acellular medial layer. Immunocytochemical staining also demonstrated the presence of beta-actin cells in the neointima of allografts while electron microscopy showed these cells to be secretory in phenotype. These results support the hypothesis that vs.mcs form an important component of the lesion of intimal hyperplasia and also propose that a phenotypic change may occur in these cells once they are present in the neointima.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781617     DOI: 10.1097/00007890-199608270-00013

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

2.  Screening of a HUVEC cDNA library with transplant-associated coronary artery disease sera identifies RPL7 as a candidate autoantigen associated with this disease.

Authors:  A T Linke; B Marchant; P Marsh; G Frampton; J Murphy; M L Rose
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

3.  Role of platelet-derived growth factor in allograft vasculopathy.

Authors:  M C Mancini; J T Evans
Journal:  Ann Surg       Date:  2000-05       Impact factor: 12.969

4.  P2Y11 Agonism Prevents Hypoxia/Reoxygenation- and Angiotensin II-Induced Vascular Dysfunction and Intimal Hyperplasia Development.

Authors:  Marie Piollet; Adrian Sturza; Stéphanie Chadet; Claudie Gabillard-Lefort; Lauriane Benoist; Danina-Mirela Muntean; Oana-Maria Aburel; Denis Angoulvant; Fabrice Ivanes
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

Review 5.  Analysis of arterial intimal hyperplasia: review and hypothesis.

Authors:  Vladimir M Subbotin
Journal:  Theor Biol Med Model       Date:  2007-10-31       Impact factor: 2.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.